EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

PubWeight™: 2.00‹?› | Rank: Top 2%

🔗 View Article (PMID 9215835)

Published in J Clin Oncol on July 01, 1997

Authors

M Bower1, E S Newlands, L Holden, D Short, C Brock, G J Rustin, R H Begent, K D Bagshawe

Author Affiliations

1: Medical Oncology Unit, Charing Cross Hospital, London, United Kingdom. m.bower@cxwms.ac.uk

Articles citing this

Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study. Lancet (2011) 1.51

Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract (2011) 1.06

The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours. Br J Cancer (2006) 1.04

Gestational trophoblastic disease: a multimodality imaging approach with impact on diagnosis and management. Radiol Res Pract (2014) 0.98

Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009. Br J Cancer (2012) 0.92

The presentation and management of post-partum choriocarcinoma. Br J Cancer (1999) 0.90

A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. Br J Cancer (2007) 0.90

The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study. Eur J Nucl Med Mol Imaging (2005) 0.90

Gestational trophoblastic neoplasia with retroperitoneal metastases: a fatal complication. World J Surg Oncol (2010) 0.89

Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease. Br J Cancer (2000) 0.87

Long term remission of metastatic placental site trophoblastic tumor (PSTT): Case report and review of literature. World J Surg Oncol (2005) 0.87

Comparison of immunohistology using pan-CK and EMA in the diagnosis of lymph node metastasis of gastric cancer, particularly micrometastasis and isolated tumor cells. Oncol Lett (2012) 0.87

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia. Br J Cancer (2012) 0.87

Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital. BMC Cancer (2015) 0.82

Gestational Choriocarcinoma Presenting with Lacrimal Gland Metastasis: A First Reported Case. Case Rep Obstet Gynecol (2015) 0.80

Gestational trophoblastic neoplasia: A 6 year retrospective study. South Asian J Cancer (2014) 0.79

Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management. J Cancer Res Clin Oncol (2004) 0.78

Clinical characteristics and prognosis of 272 postterm choriocarcinoma patients at Peking Union Medical College Hospital: a retrospective cohort study. BMC Cancer (2016) 0.77

Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate? Br J Cancer (2006) 0.76

Gestational trophoblastic neoplasia, management as per risk stratification in a developing country. Indian J Med Paediatr Oncol (2016) 0.75

Gestational choriocarcinoma complicated by infective endocarditis during chemotherapy. Gynecol Oncol Rep (2017) 0.75

The challenging management of lung choriocarcinoma. J Thorac Dis (2014) 0.75

A HELLP syndrome complicates a gestational trophoblastic neoplasia in a perimenopausal woman: a case report. BMC Cancer (2016) 0.75

High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review. Mol Clin Oncol (2016) 0.75

Gestational Trophoblastic Neoplasia: Experience from a Tertiary Care Center of India. J Obstet Gynaecol India (2015) 0.75

Disseminated disease including intra-cardiac metastasis from intermediate trophoblastic tumor of unspecified subtype, presenting in pregnancy. Gynecol Oncol Rep (2016) 0.75

The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours. Br J Cancer (2002) 0.75

Intracerebral hemorrhage cause by a ruptured oncotic aneurysm from choriocarcinoma metastasis. Asian J Neurosurg (2013) 0.75

Gestational Trophoblastic Neoplasia Treatment at the Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol (2016) 0.75

The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia. J Cancer Res Clin Oncol (2012) 0.75

Articles by these authors

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord (2006) 3.55

Risk and prognostic factors in trophoblastic neoplasia. Cancer (1976) 3.12

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer (1992) 2.91

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85

Radioimmunoassay for human chorionic gonadotrophin and luteinising hormone. Lancet (1966) 2.82

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev (1997) 2.62

T-cell epitope mapping by flow cytometry. Nat Med (1998) 2.56

Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv (1996) 2.52

The earliest electrocardiographic evidence of myocardial infarction. Br Heart J (1970) 2.37

Tumour growth and anti-mitotic action. The role of spontaneous cell losses. Br J Cancer (1968) 2.34

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord (2006) 2.28

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer (1993) 2.18

Choriocarcinoma and partial hydatidiform moles. Lancet (2000) 2.15

Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer (2000) 2.07

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol (2002) 2.06

Hydatidiform mole in England and Wales 1973-83. Lancet (1986) 2.05

Safe disposal of radioactive wastes needs physician support, direction. Mich Med (1990) 2.04

Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol (1979) 2.02

Electrocardiogram of pure left ventricular hypertrophy and its differentiation from lateral ischaemia. Br Heart J (1981) 2.02

Phase I trial of elactocin. Br J Cancer (1996) 2.01

Cancer among farmers: a meta-analysis. Ann Epidemiol (1998) 1.99

Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup. J Natl Cancer Inst (2000) 1.99

Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet (1991) 1.95

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A (1998) 1.81

Further advances in the management of malignant teratomas of the testis and other sites. Lancet (1983) 1.80

Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79

Accurate quantification of 131I distribution by gamma camera imaging. Eur J Nucl Med (1990) 1.78

Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res (1998) 1.70

Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3. Clin Oncol (R Coll Radiol) (2008) 1.68

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol (1997) 1.68

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol (1992) 1.67

Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer (2000) 1.66

Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol (2000) 1.66

A review of the role of established tumour markers. Ann Clin Biochem (1991) 1.65

The masking of antigens on trophoblast and cancer cells. Lancet (1967) 1.65

The diastolic dilemma. Br Med J (1976) 1.63

Consultation and referral patterns of family physicians. J Fam Pract (1977) 1.63

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol (1995) 1.61

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60

Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase. Br J Cancer (1969) 1.59

Effects of microwave cookery on the bacterial counts of food. J Appl Bacteriol (1965) 1.58

Education research: Bias and poor interrater reliability in evaluating the neurology clinical skills examination. Neurology (2009) 1.58

Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc (1995) 1.57

ABO blood-groups in trophoblastic neoplasia. Lancet (1971) 1.56

Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer (1990) 1.56

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol (1996) 1.54

Carboplatin or cisplatin? Lancet (1988) 1.53

Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol (1986) 1.53

Endoscopic surgery in weightlessness: the investigation of basic principles for surgery in space. Surg Endosc (2001) 1.53

Problems of an electrocardiogram reporting service. Scott Med J (1969) 1.52

Tumour-marker levels and prognosis in malignant teratoma of the testis. Br J Cancer (1980) 1.49

Phase I clinical trial of mitozolomide. Cancer Treat Rep (1985) 1.48

Chemotherapy for ovarian germ cell tumours. Eur J Cancer (1996) 1.48

Current optimum management of anaplastic germ cell tumours of the testis and other sites. Br J Urol (1986) 1.48

A rapid, sensitive and specific radioimmunoassay for human chorionic gonadotrophin. J Immunol Methods (1976) 1.47

Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. Am J Obstet Gynecol (1993) 1.45

Effect of neuraminidase on the immunogenicity of early mouse trophoblast. Nature (1968) 1.44

In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines. Br J Cancer (1999) 1.42

A policy for hypertension. Br Heart J (1975) 1.42

An electrocardiogram reporting service: its role and its risks. Br Heart J (1969) 1.42

The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour. Br J Cancer (1968) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

POMB/ACE chemotherapy for mediastinal germ cell tumours. Eur J Cancer (1997) 1.40

Value and limitations of electrocardiogram in diagnosis of slight and subacute coronary attacks. Br Med J (1968) 1.40

Chemotherapy of advanced malignant teratomas. Br J Cancer (1980) 1.40